Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Moving beyond anatomy: the future of rectal cancer management is biologically-informed, response-adapted, and patient-centered.

Clinical and translational radiation oncology·2026
Same author

Clinicogenomic and Histopathologic Analyses of Supermassive Intrahepatic Cholangiocarcinoma and the Role of Ablative Radiotherapy.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Single-photon emission computed tomography functional liver imaging to facilitate reirradiation for liver malignancies: A phase I trial.

JHEP reports : innovation in hepatology·2026
Same author

Can Patients With Recurrent or Primary Squamous Cell Carcinoma of the Anus in a Previously Irradiated Pelvis Receive Definitive Reirradiation?

Advances in radiation oncology·2026
Same author

Developmental Disorders in Children Recently Diagnosed With Cancer.

Pediatric blood & cancer·2026
Same author

Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response.

NPJ systems biology and applications·2025

Related Experiment Video

Updated: May 23, 2026

Assessing Specificity of Anticancer Drugs In Vitro
09:39

Assessing Specificity of Anticancer Drugs In Vitro

Published on: March 23, 2016

Quality assessment in oncology.

Jeffrey M Albert1, Prajnan Das

  • 1Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

International Journal of Radiation Oncology, Biology, Physics
|March 27, 2012
PubMed
Summary

Developing accurate healthcare quality indicators is crucial, especially in oncology due to its complexity. This report reviews oncology quality assessment and proposes a framework for better quality measures.

Area of Science:

  • Healthcare Quality Measurement
  • Oncology
  • Evidence-Based Practice

Background:

  • The healthcare quality improvement movement necessitates robust quality indicators.
  • Existing quality measures face challenges in validity across diverse medical specialties.
  • Oncology presents unique difficulties in quality indicator development due to delayed outcome assessment and multidisciplinary care.

Purpose of the Study:

  • To review the current status of quality assessment within the field of oncology.
  • To identify existing oncology quality indicators supported by strong evidence.
  • To propose a framework for developing and refining measures that accurately reflect oncologic care quality.

Main Methods:

  • Review of current quality assessment practices in oncology.

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Related Experiment Videos

Last Updated: May 23, 2026

Assessing Specificity of Anticancer Drugs In Vitro
09:39

Assessing Specificity of Anticancer Drugs In Vitro

Published on: March 23, 2016

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

  • Identification and evaluation of existing quality indicators based on supporting evidence.
  • Development of a proposed framework for future quality measure refinement.

    • Main Results:

    • Comparative effectiveness data are increasingly guiding evidence-based oncology practice.
    • Structure and process measures are emerging as predictors of quality outcomes in oncology.
    • A framework is proposed to enhance the identification and refinement of oncology quality indicators.

    Conclusions:

    • Scientific rigor is essential for developing and implementing healthcare quality metrics.
    • Tailored quality indicators are needed for oncology, considering its specific complexities.
    • The proposed framework aims to improve the accuracy and utility of quality measures in oncologic care.